GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Other Current Receivables

Betta Pharmaceuticals Co (SZSE:300558) Other Current Receivables : ¥4 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Other Current Receivables?

Betta Pharmaceuticals Co's Other Current Receivables for the quarter that ended in Mar. 2024 was ¥4 Mil.

Betta Pharmaceuticals Co's quarterly Other Current Receivables declined from Sep. 2023 (¥47.36 Mil) to Dec. 2023 (¥2.61 Mil) but then increased from Dec. 2023 (¥2.61 Mil) to Mar. 2024 (¥3.56 Mil).

Betta Pharmaceuticals Co's annual Other Current Receivables increased from Dec. 2021 (¥45.20 Mil) to Dec. 2022 (¥89.71 Mil) but then declined from Dec. 2022 (¥89.71 Mil) to Dec. 2023 (¥2.61 Mil).


Betta Pharmaceuticals Co Other Current Receivables Historical Data

The historical data trend for Betta Pharmaceuticals Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Other Current Receivables Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.64 6.81 45.20 89.71 2.61

Betta Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.42 67.27 47.36 2.61 3.56

Betta Pharmaceuticals Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Betta Pharmaceuticals Co Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co (SZSE:300558) Business Description

Traded in Other Exchanges
N/A
Address
No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN
Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines